Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders

Abstract

These data highlight critical aspects of CD8 +TIL heterogeneity and differentiation and suggest facilitation of CD8 +TIL differentiation as a strategy to improve HNSCC ICB response.